30 closest matches · ranked by relevance
Aortic Stenosis · Mitral Stenosis · Aortic Valve Insufficiency
Primary: Subjects With Structural Valve Deterioration — 1 Participants
Peripherally Inserted Central Catheter
Primary: Primary Safety: Incidence of Symptomatic Venous Thrombosis in Patients With a Device From the BD PowerPICC Family Used for Both Short- and Long-term Venous Access. — 1.6…
Erectile Dysfunction · Impotence
Primary: Number of Participants With Penile Prosthesis Overall Subject Satisfaction — 34; 34; 0; 0 Participants
Chest Pain
Primary: Time to Primary Endpoint — 1.0; 1.1; 1.2; 1.4 Percentage of participants with an event
Chronic Pain
Primary: Mean Change in Pain Assessed by Numerical Rating Scale (NRS) From Baseline to 3 Months — 2.3; 3.3 score on a scale
Patients With an Indication for an ICD Implantation According to the Guidelines
Primary: Analysis of Change of Episodes Inappropriately Treated by Shock Therapy Due to Smart Shock™ Technology. — 94.9 % of episodes wo shock due to SmartShock
Stable Myopic Refractive Error, With or Without Astigmatism
Primary: The Percentage of Eyes Achieving the Target of Monocular Uncorrected Visual Acuity of 20/40 or Better — 324 Eyes
Cosmetic Techniques
Primary: Patient Satisfaction With Validated FACE-Q Aesthetics Survey — 28.0; 24.0; 36.0; 36.0 score on a scale
Cardiac Rhythm Disorder · Bradycardia · Cardiac Pacemaker Artificial
Primary: Mean Rankings for Pacemaker Device Features — 2.3; 2.6; 2.2; 4.7 score on a scale
Acute Coronary Syndrome (ACS)
Primary: Prospect II: Patient Level Non-culprit Lesion Related Non-Culprit Major Adverse Cardiac Event (NC-MACE) Adjudicated to an Originally Untreated Non-culprit Lesion During…
Cystic Fibrosis
Primary: Sweat Chloride by Cohort (Part A Only) — 22.0; 81.0; 101.4 mmol/L
Degenerative Disc Disease
Primary: Number of Participants With Fusion — 50 Participants
Degenerative Disc Disease
Primary: Percentage of Participants With Fusion — 99.1 Percentage of Participants
Idiopathic Thrombocytopenic Purpura · Thrombocytopenia · Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Primary: Number of Participants Utilizing Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Therapies for First-line Treatment — 128; 37; 3; 11 Participants
Echocardiography
Primary: The Frequency of Serious Adverse Reactions (SAR)'s Among Subjects Who Receive Optison (Causally Related to the Product)During Contrast Enhanced Echocardiography in…
Atherosclerosis · Coronary Artery Disease
Primary: Cardiac Events (Composite) — 1.0 percentage of participants
Acute Ischemic Stroke
Primary: Percentage of Participants With Successful Revascularization — 98.0 Percentage of participants
Lower Limb Amputation Below Knee (Injury) · Lower Limb Amputation Above Knee (Injury) · Lower Limb Amputation Knee
Primary: Patient-perceived Mobility (PLUS-M)™ — 57.2; 56.9; 58.3; 57.6 units on a scale — p=0.286
Gastro-Intestinal Disorder
Primary: Number of Participants With Clinically Significant Endoscopic Findings — 37 Participants
Coronary Artery Disease
Primary: Primary Composite (Number) of Deaths / MIs / Invasive Coronary Angiography Without Obstructive Disease — 44; 118; 18; 12 number of events — p=<.001
Migraine
Primary: Change in Mean Headache Index Score Among Patients — -1.52 headache index score
Abdominal Aortic Aneurysm Without Rupture
Primary: Safety: Major Adverse Events (MAE) — 1; 2; 2 Number of Events
Cardiac Disease
Primary: The Left Ventricular Size (Qualitative Visual Assessment) — 100; 100 Percentage of scans obtained (%)
Pelvic Organ Prolapse (POP)
Primary: Palpability of the Restorelle Direct Fix Anterior and Posterior (A&P) — 30; 0; 0; 0 participants
Vaginal Vault Prolapse · Pelvic Organ Prolapse · Uterine Prolapse
Primary: Patient Global Impression of Improvement (PGI-I) Score — 39 Participants
Diabetes Mellitus, Type I
Primary: Changes in Glucose Variability — 7.5; 7.3; 52.8; 59.8 % time spent in range
Complication of Surgical Procedure · Acute Respiratory Failure, Adult · Postoperative Respiratory Complications
Primary: The Main Outcome, Defined as a Postoperative Pulmonary Complications (PPC), Will be a Composite of the In-hospital Fatal or Non-fatal Postoperative Events. — 7.92…
Chronic Kidney Disease
Primary: Percentage of Participants Per Facility With Hemoglobin < 10 g/dL — 11.5; 11.0; 13.1; 12.0 percentage of participants per facility
Left Ventricular Dysfunction
Primary: LV MSP Feature Related Complication-Free Rate — 99 percentage of participants
Adverse Effects in the Use of the OsteoProbe System
Primary: The Number of Participants With Reported Device Related Serious Adverse Events. — 0 Participants